Activities

  • A Different Tune: Patient-Centered Treatment of Psoriasis and Psoriatic Arthritis

    Leading dermatology/rheumatology faculty and a patient presenter led attendees through changes in the psoriasis/psoriatic arthritis landscape via an interactive activity featuring TED Talk-style presentations, patient storytelling, and a discussion. The presenters focused on advances in the clinical areas of psoriasis and psoriatic arthritis, as well as how these advances introduce changes in the lives of people suffering from psoriatic disease, the increased complexity of care, and changes in routine clinical practice due to new, increasingly efficacious treatments. The activity concluded with key teaching points and a question and answer session.

    Date: February 16, 2018

    Venue: Sheraton San Diego Hotel & Marina, San Diego, California

    Review activity content under the Materials button (below).

  • Beneath the Surface: Psoriatic Arthritis in Dermatology Practice—Simulations

    The workshop included two case simulations. Each participant was asked to work on the simulations using a provided iPad®. In each simulation, participants explored a clinical vignette of a patient with psoriasis and psoriatic arthritis (PsA) and made a treatment decision choosing from the available options. Each case simulation was discussed with the entire group of participants. As part of the workshop, the multidisciplinary faculty team delivered three fast-paced, practice-oriented presentations. The first presentation reviewed the role of dermatology providers in PsA care, highlighting the importance of screening patients with psoriasis for PsA in order to timely diagnose PsA and start treatment that can prevent or reduce joint damage. The second presentation addressed the wide range of PsA therapies and latest evidence-based recommendations for treatment of PsA. The third presentation introduced an approach for patient-provider shared decision making in the treatment of psoriasis and PsA. Throughout the workshop, participants were invited to answer questions, as well as ask questions and make comments, verbally and via iPads.

    Date: January 30, 2018 
    Venue: Haleakala Ballroom 4/5, Grand Wailea Wailea, Hawaii

    Review activity content under the Materials button (below).

  • Beneath the Surface: Psoriatic Arthritis in Your Patients with Psoriasis

    This interactive session included three practice-oriented and succinctly delivered presentations in addition to a case simulation. The first presentation reviewed the role of dermatology providers in psoriatic arthritis (PsA) care, highlighting the importance of screening patients with psoriasis for PsA in order to timely diagnose PsA and start treatment that can prevent or reduce joint damage. The second presentation addressed the wide range of PsA therapies and the latest evidence-based recommendations for treatment of PsA. The third presentation focused on appropriate monitoring of patients with PsA. In the simulation exercise, participants explored a clinical vignette of a patient with psoriasis and PsA and made a treatment decision choosing from the available options. At the end of the session, the faculty discussed patient-centered care for patients with psoriasis and PsA and invited questions from the audience.

    Date: September 29, 2018

    Venue: St. Charles Ballroom, Hilton New Orleans Riverside, New Orleans, Louisiana

    Review activity content under the Materials button (below).

  • Beneath the Surface: Psoriatic Arthritis in Your Patients With Psoriasis

    This interactive session included three practice-oriented and succinctly delivered presentations in addition to a case simulation. The first presentation reviewed the role of dermatology providers in psoriatic arthritis (PsA) care, highlighting the importance of screening patients with psoriasis for PsA in order to timely diagnose PsA and start treatment that can prevent or reduce joint damage. The second presentation addressed the wide range of PsA therapies and the latest evidence-based recommendations for treatment of PsA. The third presentation focused on appropriate monitoring of patients with PsA. In the simulation exercise, participants explored a clinical vignette of a patient with psoriasis and PsA and make a treatment decision choosing from the available options. At the end of the session, the faculty discussed patient-centered care for patients with psoriasis and PsA and invited questions from the audience.

    Date: June 23, 2018

    Venue: International Center North, The Broadmoor, Colorado Springs, Colorado

    Review activity content under the Materials button (below).

  • Chat Rheum: Elevating SDM Conversations in RA

    This interactive CME workshop sought to uncover the impact of shared decision making (SDM) on optimizing treatment decisions to achieve desired treatment targets in patients with rheumatoid arthritis (RA). Two fast-paced presentations spotlighted the strategy around SDM, including techniques to increase patient engagement and translating clinical trial evidence into good patient decisions. Next, leading faculty joined by a patient-actor staged patient-provider communication inspired by real-life scenarios. Attendees also had the option to enhance their own skills through a guided SDM practice exercise. The activity concluded with a roundtable discussion on patient-centered, team-based RA care, including time for Q&A. Throughout the workshop, participants were invited to interact verbally or via iPad® as well as explore decision aids and other provided educational resources.

    Date: October 24, 2018

    Venue: Marriott Marquis Chicago, Great Lakes Ballroom E/F, Chicago, Illinois

    Review activity content under the Materials button (below).

  • Escape Rheum: Cracking the Code to Rheumatoid Arthritis Treatment

    Many patients with rheumatoid arthritis (RA) do not have their disease adequately controlled, and only a minority achieve consistent remission or low disease activity. This activity was designed to sharpen participants’ understanding of the evolving therapeutic landscape for RA and equip them with forward-thinking, patient-centered communication strategies. Through a combination of a mechanism of action (MOA) video, TED Talks-style presentations, a clinical case study, and a large-group discussion, participants explored MOAs of targeted therapies, the latest evidence on clinical efficacy and safety of JAK inhibitors, disease activity measures to guide treatment decisions, and use of decision aids.

    Date: September 28, 2019

    Venue:
    Hotel del Coronado, San Diego, California

    Review activity content under the Materials button (below).

  • Escape Rheum: Cracking the Code to Rheumatoid Arthritis Treatment

    Many patients with rheumatoid arthritis (RA) do not have their disease adequately controlled, and only a minority achieve consistent remission or low disease activity. This activity was designed to sharpen participants’ understanding of the evolving therapeutic landscape for RA and equip them with forward-thinking, patient-centered communication strategies. Through a combination of a mechanism of action (MOA) video, TED Talks-style presentations, a clinical case study, and a large-group discussion, participants explored MOAs of targeted therapies, the latest evidence on clinical efficacy and safety of JAK inhibitors, disease activity measures to guide treatment decisions, and use of decision aids.

    Date: May 4, 2019

    Venue:
    Hilton Sandestin Beach Golf Resort & Spa, Emerald Ballroom, Destin, Florida

    Review activity content under the Materials button (below).

  • New Heights in Patient Care: Elevating Science in Treating Psoriasis, Psoriatic Arthritis, and Atopic Dermatitis

    Fast-paced and focused on emerging science and treatment techniques, New Heights in Patient Care was an interactive activity designed to sharpen participants’ understanding of psoriasis, psoriatic arthritis (PsA), and atopic dermatitis (AD) and equip them with forward-thinking, patient-centered communication strategies. Through a combination of medical animation, TED Talks-style presentations, a clinical case study, and a discussion of patient-provider shared decision making, learners explored disease pathophysiology, mechanisms of action (MOAs) of targeted therapies, evidence-based treatment recommendations, and use of decision aids.

    Date: October 4, 2019

    Venue:
    Grand Ballroom AB, The Omni Grove Park Inn, Asheville, North Carolina

    Review activity content under the Materials button (below).

  • PsA+COVID-19: Augmented Reality and Patient Engagement in the Treatment of Psoriatic Arthritis

    COVID-19 has impacted psoriatic arthritis (PsA) patient care in many ways, particularly for patients with multiple comorbidities. This interactive activity reviews clinical practice guidelines addressing COVID-19 infection and vaccination that are relevant to patients with PsA, highlights effectiveness and safety of therapies for PsA, and offers a self-directed experience of building and solving patient cases to learn from making decisions and receiving immediate feedback. This activity also incorporates the patient perspective, a skill-oriented presentation on engaging patients in shared decision making, decision aids, and a demonstration of an augmented reality (AR) app on PsA for healthcare providers and patients.

    Please download the ImmerseRx: Psoriatic Arthritis augmented reality app on your mobile device to gain the most benefit from participation in this activity. You may use one of the QR codes below or search for it in the Google Play or App Store

    Scan for Google Play Store Scan for Apple Store

    This activity is one of four in this series, PsA+COVID-19: Innovations and Tools for Patient-Centered Psoriatic Arthritis Care.

    For the best experience, use a laptop, desktop, or tablet with the Google Chrome browser.

    Release Date: June 14, 2021
    Expiration Date: June 14, 2022

  • PSA+COVID-19: Conference Highlights From ACR Convergence 2020

    This 30-minute live CME broadcast focused on highlights from the ACR Convergence 2020 conference. Learners were provided new evidence regarding psoriatic arthritis (PsA) in the context of COVID-19, presented in a clinical discussion with the prominent rheumatology expert in this clinical area. This broadcast featured the latest data synthesized to provide information most relevant to clinical practice. Topics included efficacy and safety of existing and novel targeted therapies for PsA and strategies for minimizing the risk of infections and adverse events for patients with PsA at the time of the COVID-19 pandemic.

    Release Date: November 17, 2020
    Valid Until: N/A (this was a live one-day activity)

  • PSA+COVID-19: Conference Highlights From ACR Convergence 2020

    This 30-minute on-demand broadcast focuses on highlights from the ACR Convergence 2020 conference. You will learn about new evidence regarding psoriatic arthritis (PsA) in the context of COVID-19, presented in a clinical discussion with the prominent rheumatology expert in this clinical area. This broadcast features the latest data synthesized to provide information most relevant to clinical practice. Topics include efficacy and safety of existing and novel targeted therapies for PsA and strategies for minimizing the risk of infections and adverse events for patients with PsA at the time of the COVID-19 pandemic.  

    Release Date: November 24, 2020
    Valid Until: November 24, 2021

  • PSA+COVID-19: Connecting on Patient Care During a Pandemic

    COVID-19 has made providing care to patients with psoriasis and psoriatic arthritis (PsA) more uncertain and complex. This 30-minute online activity is presented by the nationally and internationally recognized rheumatology expert who will review recommendations relevant to treatment of PsA by American College of Rheumatology, National Psoriasis Foundation, Group for Research and Assessment of Psoriasis and Psoriatic Arthritis, and European League Against Rheumatism. The presenter also discusses how COVID-19 has impacted rheumatology community views on the use of biologic therapies. This activity features data and clinical scenarios that support and illustrate accurate evaluation of the benefit-to-risk ratio of immunosuppressive therapeutic interventions for PsA. It also covers treatment decisions about initiating, delaying, or stopping, PsA treatment with a conventional, targeted synthetic, or biologic disease-modifying antirheumatic drug (DMARD).   

    Release Date: November 18, 2020
    Valid Until: November 18, 2021

  • PsA+COVID-19: Virtual Solutions and Personalized Learning That Optimize Psoriatic Arthritis Care

    The COVID-19 pandemic has added uncertainty and complexity to providing care to patients with psoriatic disease. Appropriate use of strategies and tools that support providing rheumatology care remotely is critical in today’s clinical encounters. This educational activity addresses these issues through a variety of innovative experiences. First, Dr. Philip Mease and Dr. Alvin Wells present a fascinating look at immune activation and targeted therapies in psoriatic arthritis (PsA) through augmented reality. Participants are invited to join this experience via their mobile device. The activity also features a concise overview of the latest American College of Rheumatology’s clinical practice guidelines related to COVID-19, a self-directed exercise in building and exploring patient cases, and best practices for telemedicine. 

    To gain the most benefit from participation in this activity, please download the ImmerseRx: Psoriatic Arthritis augmented reality app on your mobile device. You may use one of the QR codes below or search for it in the Google Play or App Store. You may also find it helpful to download and print the worksheet before starting the activity. 

    Scan for Google Play Store Scan for Apple Store

    Release Date: March 25, 2021
    Valid Until Date: March 25, 2022

  • Share, Learn, Engage: Novel Targeted Therapies in the Treatment of Systemic Lupus Erythematosus

    Immerse yourself in this 60-minute interactive activity to meet a patient with systemic lupus erythematosus (SLE), view concise presentations, and engage in hands-on experience with the content. This activity will highlight the immunopathogenesis of SLE and mechanisms of action of therapies. Additionally, leading clinical experts will review clinical trial data and outcomes, both available and emerging, and translate them into clinically meaningful information for patient careThis activity is one of two in the series, Systemic Lupus Erythematosus: Patient-Centered Care to Improve Disease Control. 

    Release Date: May 21, 2021
    Valid Until: May 21, 2022

    For the best experience, use a laptop, desktop, or tablet with the Google Chrome browser. 

  • Share, Learn, Engage: Setting and Achieving Treatment Targets in Systemic Lupus Erythematosus

    In this 60-minute activity, participants will improve their ability to assess systemic lupus erythematosus (SLE) disease activity and treatment outcomes by viewing presentations, engaging in a case study, and exploring various measures in a matching exercise. This activity will also help bridge the gap between patients’ perceptions of their disease and healthcare providers’ assessment. The SLE clinical expert and the patient will demonstrate effective patient engagement strategies—in particular, shared decision making using a decision aid—to achieve optimal, measurable therapeutic outcomes that advance care for patients living with SLE.This activity is one of two in the series, Systemic Lupus Erythematosus: Patient-Centered Care to Improve Disease Control.

    Release Date: April 9, 2021
    Valid Until: April 9, 2022

    For the best experience, use a laptop, desktop, or tablet with the Google Chrome browser. 

  • Steps Ahead: Emerging Therapies in Psoriatic Arthritis

    Steps Ahead: Emerging Therapies in Psoriatic Arthritis was a fast-paced workshop featuring real-life scenarios and discussions designed to provide new ideas, answers, and confidence in treating PsA. Through a series of presentations and exercises, attendees covered a range of diagnosis and therapeutic options, opportunities, and outcomes to ultimately gain a deeper understanding on how to better address care gaps and move the treatment of PsA forward.

    Date and Time: September 14, 2018

    Venue: Encore at Wynn, Las Vegas, Nevada
     
    Review activity content under the Materials button (below).
     
  • The Space Between: Connecting the Science of Targeted PsA Therapies to Patient Care

    This virtual activity was held in conjunction with Congress of Clinical Rheumatology (CCR) West. Improving care for patients with psoriatic arthritis (PsA) is profoundly boosted by facilitating better patient-provider communication and implementing targeted treatment strategies. This CME activity took participants on a journey to look into the space between science and practice to enhance participants’ adeptness through innovative experiential learning and presentations. The expert presenters demonstrated mechanisms of action (MOAs) of therapies using an interactive animation. They also discussed effectiveness and safety of existing and emerging targeted treatments for PsA and presented on a patient-provider shared decision making. Learners gained expertise in the main pathways of immune activation and built inspiration to translate recent scientific advances into patient-centered care.

     

    Release Date: October 10, 2020
    Valid Until Date: October 10, 2021

  • The Space Between: Connecting the Science of Targeted PsA Therapies to Patient Care

    This virtual activity was held in conjunction with Congress of Clinical Rheumatology (CCR) East. Improving care for patients with psoriatic arthritis (PsA) is profoundly boosted by facilitating better patient-provider communication and implementing targeted treatment strategies. This CME activity took participants on a journey to look into the space between science and practice to enhance participants’ adeptness through innovative experiential learning and presentations. The expert presenters demonstrated mechanisms of action (MOAs) of therapies using an interactive animation. They also discussed effectiveness and safety of existing and emerging targeted treatments for PsA and presented on a patient-provider shared decision making. Learners gained expertise in the main pathways of immune activation and built inspiration to translate recent scientific advances into patient-centered care. 

    Release Date: September 12, 2020
    Valid Until Date: September 12, 2021